| First Author | Liao J | Year | 2015 |
| Journal | Nat Commun | Volume | 6 |
| Pages | 8977 | PubMed ID | 26611836 |
| Mgi Jnum | J:228003 | Mgi Id | MGI:5704249 |
| Doi | 10.1038/ncomms9977 | Citation | Liao J, et al. (2015) The NLRP3 inflammasome is critically involved in the development of bronchopulmonary dysplasia. Nat Commun 6:8977 |
| abstractText | The pathogenesis of bronchopulmonary dysplasia (BPD), a devastating lung disease in preterm infants, includes inflammation, the mechanisms of which are not fully characterized. Here we report that the activation of the NLRP3 inflammasome is associated with the development of BPD. Hyperoxia-exposed neonatal mice have increased caspase-1 activation, IL1beta and inflammation, and decreased alveolarization. Nlrp3(-/-) mice have no caspase-1 activity, no IL1beta, no inflammatory response and undergo normal alveolarization. Treatment of hyperoxia-exposed mice with either IL1 receptor antagonist to block IL1beta or glyburide to block the Nlrp3 inflammasome results in decreased inflammation and increased alveolarization. Ventilated preterm baboons show activation of the NLRP3 inflammasome with increased IL1beta:IL1ra ratio. The IL1beta:IL1ra ratio in tracheal aspirates from preterm infants with respiratory failure is predictive of the development of BPD. We conclude that early activation of the NLRP3 inflammasome is a key mechanism in the development of BPD, and represents a novel therapeutic target for BPD. |
